Clinical Trial Update: Low-dose Interleukin-2 in Women With Unexplained Miscarriages [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trials evaluated low-dose interleukin-2 in women with recurrent miscarriage; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Recurrent Miscarriage | Phase 1, Phase 2 | Status: COMPLETED